<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03864172</url>
  </required_header>
  <id_info>
    <org_study_id>InternationalMU</org_study_id>
    <nct_id>NCT03864172</nct_id>
  </id_info>
  <brief_title>Soluble Corn Fiber on BMD in Pre-pubertal Boys and Girls (PREBONE-Kids)</brief_title>
  <acronym>PREBONE-Kids</acronym>
  <official_title>Effects of Soluble Corn Fiber on BMC, BMD and Bone Biomarkers of Pre-pubertal Boys and Girls : a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tate &amp; Lyle</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>International Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effects of soluble corn fiber (SCF) on bone
      mineral content (BMC) and bone mineral density (BMD) in pre-pubertal boys and girls. The
      hypothesis to be tested is: SCF will lead to greater increase of BMD, as measured with
      densitometry in both low calcium as well as high calcium intakes compared to placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Main objective To investigate the effects of soluble corn fiber (SCF) supplementation on bone
      mineral content (BMC) and bone mineral density (BMD) in pre-pubertal boys and girls.

      Secondary objectives

      The secondary objectives are:

      To investigate changes in bone formation and bone resorption markers in response to soluble
      corn fiber supplementation in the diet of prepubertal boys and girls consuming adequate
      calcium intake vs placebo To investigate changes in body composition in response to soluble
      corn fiber supplementation in the diet of prepubertal boys and girls consuming adequate
      calcium intake vs placebo

      Hypothesis Soluble corn fiber would lead to improved BMC and BMD accrual in pre-pubertal
      children compared to placebo.

      Study design The proposed study is a double blind, randomized, single center, parallel design
      trial

      Duration of study The duration of the study intervention would be 12 months
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2, 2017</start_date>
  <completion_date type="Actual">August 1, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised controlled Trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blind study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density ( BMD)</measure>
    <time_frame>12 months</time_frame>
    <description>BMD at total body and lumbar spine L1-L4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone mineral content (BMC)</measure>
    <time_frame>12 months</time_frame>
    <description>BMC at total body and lumbar spine L1-L4</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone biomarkers</measure>
    <time_frame>12 months</time_frame>
    <description>Serum CTX1, P1NP, osteocalcin &amp; BAP</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">243</enrollment>
  <condition>Bone Health</condition>
  <arm_group>
    <arm_group_label>Usual intake + placebo fruit juice</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo fruit flavoured juice powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual intake +SCF fruit juice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fruit flavoured juice powder added with 12 g soluble corn fiber (SCF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adequate calcium +fruit juice placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placebo fruit flavoured juice powder added with 600 mg calcium to meet RNI intake</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adequate calcium + SCF fruit juice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fruit flavoured juice powder added with 12 g soluble corn fiber (SCF) and 600 mg calcium to meet RNI intake</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Usual intake + placebo fruit juice</intervention_name>
    <description>Participants will consume 200 mls of placebo fruit flavoured juice</description>
    <arm_group_label>Usual intake + placebo fruit juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Usual intake+SCF fruit juice</intervention_name>
    <description>Participants will consume 200 mls of fruit flavoured juice containing 12 g soluble corn fiber (SCF)</description>
    <arm_group_label>Usual intake +SCF fruit juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Adequate calcium + placebo fruit juice</intervention_name>
    <description>Participants will consume 200 mls of placebo fruit flavoured juice added with 600 mg calcium to meet RNI</description>
    <arm_group_label>Adequate calcium +fruit juice placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Adequate calcium+ SCF fruit juice</intervention_name>
    <description>Participants will consume 200 mls of fruit flavoured juice containing 12 g soluble corn fiber (SCF) added with 600 mg calcium to meet RNI</description>
    <arm_group_label>Adequate calcium + SCF fruit juice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Screened to be generally healthy as determined by standard medical assessment on
             physical and mental health

          -  Tanner stage 2 based on breast development for girls, and pubic hair in boys. Girls
             will have to be premenarcheal

          -  Having obtained his/her informed consent and parents or legal guardians consent

        Exclusion Criteria:

          -  History of serious medical conditions such as intestinal or severe metabolic diseases,
             disorders such as diabetes, renal, hepatic or pancreatic diseases, disorders, ulcer,
             hyperthyroidism, malignance, chronic malnutrition, anaemia

          -  History or on therapy with medication known to interfere with bone metabolism such as
             steroids, hormones, diuretics, cortisone or anti-seizure medication

          -  Taking regularly any nutritional supplements and unwilling to stop for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Winnie SS Chee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Medical University</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>57000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2019</study_first_posted>
  <last_update_submitted>August 7, 2019</last_update_submitted>
  <last_update_submitted_qc>August 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>International Medical University</investigator_affiliation>
    <investigator_full_name>Winnie Chee</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

